Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma

Published:2022-02-01 Issue:3 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Yi Shuhua,Yan Yuting,Jin Meiling,Bhattacharya Supriyo^ORCID,Wang Yi,Wu Yiming^ORCID,Yang Lu,Gine Eva,Clot Guillem^ORCID,Chen Lu,Yu Ying,Zou Dehui,Wang Jun,Phan An T.^ORCID,Cui Rui,Li Fei^ORCID,Sun Qi,Zhai Qiongli,Wang Tingyu,Yu Zhen,Liu Lanting,Liu Wei^ORCID,Lyv Rui,Sui Weiwei,Huang Wenyang,Xiong Wenjie,Wang Huijun,Li Chengwen,Xiao Zhijian^ORCID,Hao Mu,Wang Jianxiang,Cheng Tao,Bea Silvia,Herrera Alex F.^ORCID,Danilov Alexey,Campo Elias^ORCID,Ngo Vu N.,Qiu Lugui^ORCID,Wang Lili

Funder

NIH and other resources

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/153283/files/pdf

Reference66 articles.

1. Update on mantle cell lymphoma

2. Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

3. Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma

4. Mantle cell lymphoma: evolving management strategies

5. Molecular pathogenesis of mantle cell lymphoma

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SP140-RESIST pathway regulates interferon mRNA stability and antiviral immunity;2024-08-29

2. CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression;Blood Advances;2024-08-16

3. Prospects for liquid biopsy approaches in lymphomas;Leukemia & Lymphoma;2024-08-10

4. SOHO State of the Art Updates and Next Questions: Treatment Evolution of Mantle Cell Lymphoma: Navigating the Different Entities and Biological Heterogeneity of Mantle Cell Lymphoma in 2024;Clinical Lymphoma Myeloma and Leukemia;2024-08

5. PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma;Cancer Letters;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3